News

Biotech Reports Encouraging Efficacy Data in Wet AMD, Target Price Raised 66%

June 24, 2021 (Investorideas.com Newswire) These new results, from a Clearside Biomedical trial, are presented and interpreted in a ROTH Capital Partners report.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:News